致癌RNA结合蛋白 HuR 的类似药物分子降解剂
Liann Kassabri1, Raphael I Benhamou1
1The Institute for Drug Research of the School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem 91121, Israel.
JACS Au
|August 29, 2025
概括
使用分子和PROTAC,针对Hu抗原R (HuR) 蛋白的小分子有效地减少了癌细胞的生长. 这种针对性蛋白质降解策略对治疗侵袭性乳腺癌和其他RNA驱动性疾病具有前景.
科学领域:
- 癌症学
- 分子生物学
- 药物发现
背景情况:
- 胡抗原R (HuR) 或ELAVL1是一种关键的RNA结合蛋白,与乳腺癌的进展有关.
- 升高的HuR水平与乳腺癌的扩散,存活率和转移率的增加有关.
- 针对HuR是一种潜在的治疗策略,用于侵袭性乳腺癌亚型.
研究的目的:
- 使用分子和PROTAC技术开发和评估针对HuR的小分子降解剂.
- 评估这些降解剂在降低HuR水平和抑制乳腺癌细胞表型方面的有效性.
- 探索针对性蛋白质降解对HuR驱动的癌症的治疗潜力.
主要方法:
- 开发利用分子和蛋白质溶解向奇美拉 (PROTAC) 技术的小分子降解剂.
- 评估HuR降解及其对乳腺癌细胞系的mRNA水平的影响.
- 在2D和3D球形模型中评估细胞表型,并评估降解剂的药物相似性.
主要成果:
- 有效的小分子降解剂通过双相降解特征显著降低了乳腺癌细胞中的HuR水平.
- 降解剂在体外降低了与HuR相关的mRNA表达并抑制了癌细胞表型.
- 这种降解剂具有有利的药物特性.
结论:
- 分子和PROTAC有效降低HuR,这是乳腺癌进展的关键因素.
- 针对性蛋白质降解为向结构动态RNA结合蛋白 (如HuR) 提供了可行的策略.
- 这些发现突显了乳腺癌和其他RNA介导疾病的有前途治疗途径.
更多相关视频
13:34Method for the Isolation and Identification of mRNAs, microRNAs and Protein Components of Ribonucleoprotein Complexes from Cell Extracts using RIP-Chip
Published on: September 29, 2012
27.7K
11:11Desthiobiotin-Streptavidin-Affinity Mediated Purification of RNA-Interacting Proteins in Mesothelioma Cells
Published on: April 25, 2018
8.3K
相关概念视频
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
Types of RNA
64.8K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
64.8K
MicroRNAs
21.7K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.7K
RNA Interference
26.4K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.4K
Nuclear Export of mRNA
7.9K
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
7.9K
siRNA - Small Interfering RNAs
17.0K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.0K
